Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alonso Soto1,2, Dante M Quiñones-Laveriano1, Patricia J Garcia3

  • 1Instituto de Investigación en Ciencias Biomédicas, Universidad Ricardo Palma, Lima, Perú.

Revista Peruana De Medicina Experimental Y Salud Publica
|September 3, 2020
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of the performance of four clinical prediction rules for mortality in patients with COVID-19.

PloS one·2026
Same author

Health system use and experience among people with poor mental health: A cross-sectional analysis of the People's Voice Survey in 18 countries.

PLoS medicine·2026
Same author

Epidemiology of adult T-cell leukemia/lymphoma (ATL) in people living with HTLV-1: A 30-year study in Peru.

PLoS neglected tropical diseases·2026
Same author

Severe thrombocytopenia following exposure to orlistat, alkylphenol, and pyrethroids: coincidence or causation?

Revista peruana de medicina experimental y salud publica·2026
Same author

"What's the point, when we're already dead?" Implementation challenges of COVID-19 public policies for indigenous peoples in the Peruvian Amazon: A sequential multi-method qualitative study.

PloS one·2026
Same author

Challenges in the medical oxygen ecosystem of Peru: A political economy analysis.

PLOS global public health·2025

The SOLIDARITY clinical trial rapidly evaluated treatments for COVID-19. This large international study compared hydroxychloroquine, lopinavir/ritonavir, interferon, and remdesivir against standard care for patients with moderate to severe disease.

Area of Science:

  • Global Health
  • Infectious Diseases
  • Clinical Trials

Background:

  • COVID-19 presents a significant global health crisis requiring urgent research.
  • Conducting rigorous clinical trials necessitates collaboration among sponsors, researchers, regulatory bodies, and ethics committees.
  • There is an ethical imperative to find effective treatments for patients suffering from COVID-19.

Purpose of the Study:

  • To rapidly evaluate the efficacy of potential treatments for COVID-19.
  • To assess the benefits of hydroxychloroquine, lopinavir/ritonavir, interferon, and remdesivir in patients with moderate to severe COVID-19.
  • To compare these investigational drugs against standard therapy.

Main Methods:

  • SOLIDARITY is a large-scale, international, multi-center clinical trial.

Related Experiment Videos

  • Thousands of subjects with moderate to severe COVID-19 were recruited.
  • Participants were randomly assigned to receive hydroxychloroquine, lopinavir/ritonavir (with or without interferon), remdesivir, or standard therapy.

    • Main Results:

    • The study aimed to quickly identify effective treatments for COVID-19.
    • Results will determine if any of the evaluated drugs offer a real benefit compared to standard care.
    • Peru's participation expands the trial's reach for broader data collection.

    Conclusions:

    • The SOLIDARITY trial is crucial for identifying effective COVID-19 treatments.
    • International collaboration is key to addressing global health emergencies like the COVID-19 pandemic.
    • Evidence generated will guide clinical practice and patient care for COVID-19.